PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 281 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 6.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $295 | -23.6% | 9,623 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $386 | -1.8% | 9,623 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $393 | +5.6% | 9,623 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $372 | -99.9% | 9,623 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $512,000 | -8.7% | 9,623 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $561,000 | -23.6% | 9,623 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $734,000 | +26.8% | 9,623 | 0.0% | 0.00% | +33.3% |
| Q4 2021 | $579,000 | +7.4% | 9,623 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $539,000 | -7.7% | 9,623 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $584,000 | +22.2% | 9,623 | +41.0% | 0.00% | 0.0% |
| Q1 2021 | $478,000 | +17.2% | 6,823 | 0.0% | 0.00% | +50.0% |
| Q4 2020 | $408,000 | -0.5% | 6,823 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $410,000 | -42.7% | 6,823 | -50.0% | 0.00% | 0.0% |
| Q2 2020 | $716,000 | – | 13,646 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
| Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
| GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
| ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
| RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
| AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
| 1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
| ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
| OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
| Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |